Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-03 5:10 pm Purchase | 13D | PYXIS ONCOLOGY INC PYXS | Sullivan Lara | 5,489,699 8.89% | 1,319,425 (+31.64%) | View |
| 2024-03-08 4:03 pm Purchase | 13G | PYXIS ONCOLOGY INC PYXS | Deep Track Capital LP | 4,184,100 7.87% | 4,184,100 (New Position) | View |
| 2024-02-14 4:00 pm Sale | 13G | PYXIS ONCOLOGY INC PYXS | TANG CAPITAL PARTNERS LP | 0 0% | -3,470,700 (Position Closed) | View |
| 2024-02-14 09:28 am Sale | 13G | PYXIS ONCOLOGY INC PYXS | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -2,938,851 (Position Closed) | View |
| 2024-01-26 4:36 pm Purchase | 13G | PYXIS ONCOLOGY INC PYXS | Ridgeback Capital Investments L.P. | 4,345,228 9.8% | 4,345,228 (New Position) | View |
| 2023-04-04 4:58 pm Purchase | 13D | PYXIS ONCOLOGY INC PYXS | Sullivan Lara | 4,170,274 10.2% | 703,379 (+20.29%) | View |
| 2023-03-23 4:20 pm Purchase | 13G | PYXIS ONCOLOGY INC PYXS | PFIZER INC PFE | 7,032,770 19.02% | 1,811,594 (+34.70%) | View |
| 2023-02-14 4:45 pm Sale | 13G | PYXIS ONCOLOGY INC PYXS | RA CAPITAL MANAGEMENT L.P. | 0 0% | -2,282,173 (Position Closed) | View |
| 2023-02-14 4:00 pm Purchase | 13G | PYXIS ONCOLOGY INC PYXS | TANG CAPITAL PARTNERS LP | 3,470,700 9.9% | 1,489,274 (+75.16%) | View |
| 2023-02-14 10:00 am Sale | 13G | PYXIS ONCOLOGY INC PYXS | RTW INVESTMENTS LP | 0 0% | -2,120,760 (Position Closed) | View |
| 2023-02-13 6:13 pm Purchase | 13G | PYXIS ONCOLOGY INC PYXS | BIOTECHNOLOGY VALUE FUND L P | 2,938,851 8.4% | 1,147,500 (+64.06%) | View |
| 2023-02-13 5:14 pm Purchase | 13G | PYXIS ONCOLOGY INC PYXS | PFIZER INC PFE | 5,221,176 14.88% | 2,229,654 (+74.53%) | View |
| 2023-02-08 5:14 pm Purchase | 13G | PYXIS ONCOLOGY INC PYXS | Laurion Capital Management LP | 3,170,803 9% | 3,170,803 (New Position) | View |
| 2022-11-04 4:00 pm Purchase | 13G | PYXIS ONCOLOGY INC PYXS | TANG CAPITAL PARTNERS LP | 1,981,426 5.6% | 1,981,426 (New Position) | View |
| 2022-05-23 06:15 am Purchase | 13D | PYXIS ONCOLOGY INC PYXS | Sullivan Lara | 3,466,895 9.6% | 1,153,531 (+49.86%) | View |
| 2022-02-14 4:11 pm Purchase | 13G | PYXIS ONCOLOGY INC PYXS | RA CAPITAL MANAGEMENT L.P. | 2,282,173 7% | 367,239 (+19.18%) | View |
| 2022-02-14 08:51 am Purchase | 13G | PYXIS ONCOLOGY INC PYXS | RTW INVESTMENTS LP | 2,120,760 6.5% | 2,120,760 (New Position) | View |
| 2022-02-11 4:35 pm Purchase | 13G | PYXIS ONCOLOGY INC PYXS | Bayer World Investments B.V. | 2,742,338 8.4% | 2,742,338 (New Position) | View |
| 2022-02-11 4:26 pm Purchase | 13G | PYXIS ONCOLOGY INC PYXS | PFIZER INC PFE | 2,991,522 9.13% | 2,991,522 (New Position) | View |
| 2021-12-20 5:23 pm Purchase | 13G | PYXIS ONCOLOGY INC PYXS | BIOTECHNOLOGY VALUE FUND L P | 1,791,351 5.5% | 1,791,351 (New Position) | View |